ArticleThe Lancet. Microbe2021

Potential contribution of HIV during first-line tuberculosis treatment to subsequent rifampicin-monoresistant tuberculosis and acquired tuberculosis drug resistance in South Africa: a retrospective molecular epidemiology study.

Helen Cox et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.